Daniel Kisner, Harry Hixson, Jr., James Burns, Hiroyuki Mitani, Barnstead Genevac, Millipore | GenomeWeb


Daniel Kisner resigned this week from the board of directors of Sequenom, on which he had served as a member of the audit committee. The board has appointed Harry Hixson, Jr., one of its existing independent directors to fill the vacancy, the company reported.

James Burns was appointed to Ciphergens' board of directors this week, the company said in a statement. Burns is president, CEO, and a director of EntreMed, which he joined in 2004.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.